What is the current valuation of the UK Cell Banking Outsourcing Market?

As of 2024, the market valuation was 0.492 USD Billion. Read More

What is the projected market size for the UK Cell Banking Outsourcing Market by 2035?

The market is projected to reach 1.67 USD Billion by 2035. Read More

What is the expected CAGR for the UK Cell Banking Outsourcing Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 11.72%. Read More

Which companies are considered key players in the UK Cell Banking Outsourcing Market?

Key players include Lonza Group AG, Fujifilm Diosynth Biotechnologies, and Thermo Fisher Scientific Inc. Read More

What are the primary applications driving the UK Cell Banking Outsourcing Market?

Key applications include Cell Line Development, Biobanking, and Cell Therapy, with valuations ranging from 0.07 to 0.52 USD Billion. Read More

How does the market segment by cell type in the UK Cell Banking Outsourcing Market?

The market segments by cell type include Stem Cells, Somatic Cells, and Immortalized Cell Lines, with values from 0.05 to 0.52 USD Billion. Read More

What services are included in the UK Cell Banking Outsourcing Market?

Services include Cell Storage, Cell Processing, and Quality Control, with valuations between 0.07 and 0.52 USD Billion. Read More

Who are the primary end users of the UK Cell Banking Outsourcing Market?

Primary end users include Pharmaceutical Companies, Biotechnology Firms, and Academic Institutions, with market values from 0.05 to 0.7 USD Billion. Read More

What trends are influencing the growth of the UK Cell Banking Outsourcing Market?

Trends such as advancements in regenerative medicine and increased demand for biobanking are likely influencing market growth. Read More

How does the UK Cell Banking Outsourcing Market compare to other regions?

While specific regional comparisons are not provided, the UK market is expected to grow robustly, reflecting a strong demand for cell banking services. Read More

UK Cell Banking Outsourcing Market

ID: MRFR/HC/49573-HCR

200 Pages

Vikita Thakur

Last Updated: May 12, 2026

UK Cell Banking Outsourcing Market Research Report: By Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Cord Stem Cell Banking, Embryonic Stem Cell Banking, Adult Stem Cell Banking, Dental Stem Cell Banking, IPS Stem Cell Banking, Non-Stem Cell Banking) andBy Application (Cell Bank Storage, Master Cell Bank Storage, Working Cell Bank Storage, Cell Storage Stability Testing, Cell Bank Preparation, Master Cell Bank Preparation, Working Cell Bank Preparation, Bank Characterization & Testing, Viral Cell Bank Safety Testing, Microbial Cell Bank Safety Testing, Gene Expression Testing, Karyology Testing, Gene Sequencing Testing)- Forecast to 2035 UK Cell Banking Outsourcing Market Overview: As per MRFR analysis, the UK Cell Banking Outsourcing Market Size was estimated at 44

UK Cell Banking Outsourcing Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)11.72%

2018 Market Size$ 44.97 Million

2024 Market Size$ 0.49 Billion

2035 Market Size$ 1.67 Billion

Key Players

Lonza Group AG

Fujifilm Diosynth Biotechnologies

Thermo Fisher Scientific Inc.

Merck KGaA

Charles River Laboratories

Celerion

Trends

Increased Demand for Personalized Medicine
Regulatory Compliance and Quality Assurance
Technological Advancements in Cell Preservation

Opportunities

Growing Focus on Cost Efficiency
Regulatory Framework and Compliance
Technological Innovations in Cell Banking

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 UK Cell Banking Outsourcing Market, BY Application (USD Billion) | |
  1. 4.1.1 Cell Line Development | |
  2. 4.1.2 Biobanking | |
  3. 4.1.3 Cell Therapy | |
  4. 4.1.4 Regenerative Medicine | |
  5. 4.1.5 Research and Development |
2. 4.2 UK Cell Banking Outsourcing Market, BY Cell Type (USD Billion) | |
  1. 4.2.1 Stem Cells | |
  2. 4.2.2 Somatic Cells | |
  3. 4.2.3 Germ Cells | |
  4. 4.2.4 Immortalized Cell Lines | |
  5. 4.2.5 Primary Cells |
3. 4.3 UK Cell Banking Outsourcing Market, BY Service Type (USD Billion) | |
  1. 4.3.1 Cell Storage | |
  2. 4.3.2 Cell Processing | |
  3. 4.3.3 Cell Distribution | |
  4. 4.3.4 Quality Control | |
  5. 4.3.5 Regulatory Compliance |
4. 4.4 UK Cell Banking Outsourcing Market, BY End User (USD Billion) | |
  1. 4.4.1 Pharmaceutical Companies | |
  2. 4.4.2 Biotechnology Firms | |
  3. 4.4.3 Academic Institutions | |
  4. 4.4.4 Research Organizations | |
  5. 4.4.5 Contract Research Organizations 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the UK Cell Banking Outsourcing Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the UK Cell Banking Outsourcing Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Lonza Group AG (CH) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Fujifilm Diosynth Biotechnologies (GB) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Thermo Fisher Scientific Inc. (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Merck KGaA (DE) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Charles River Laboratories (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Celerion (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 BioLife Sciences (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Cytiva (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 UK MARKET ANALYSIS BY APPLICATION |
6. 6.3 UK MARKET ANALYSIS BY CELL TYPE |
7. 6.4 UK MARKET ANALYSIS BY SERVICE TYPE |
8. 6.5 UK MARKET ANALYSIS BY END USER |
9. 6.6 KEY BUYING CRITERIA OF UK CELL BANKING OUTSOURCING MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF UK CELL BANKING OUTSOURCING MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: UK CELL BANKING OUTSOURCING MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: UK CELL BANKING OUTSOURCING MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: UK CELL BANKING OUTSOURCING MARKET |
15. 6.12 UK CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 UK CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion) |
17. 6.14 UK CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2024 (% SHARE) |
18. 6.15 UK CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2024 TO 2035 (USD Billion) |
19. 6.16 UK CELL BANKING OUTSOURCING MARKET, BY SERVICE TYPE, 2024 (% SHARE) |
20. 6.17 UK CELL BANKING OUTSOURCING MARKET, BY SERVICE TYPE, 2024 TO 2035 (USD Billion) |
21. 6.18 UK CELL BANKING OUTSOURCING MARKET, BY END USER, 2024 (% SHARE) |
22. 6.19 UK CELL BANKING OUTSOURCING MARKET, BY END USER, 2024 TO 2035 (USD Billion) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
  2. 7.2.2 BY CELL TYPE, 2026-2035 (USD Billion) | |
  3. 7.2.3 BY SERVICE TYPE, 2026-2035 (USD Billion) | |
  4. 7.2.4 BY END USER, 2026-2035 (USD Billion) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

UK Cell Banking Outsourcing Market Segmentation

UK Cell Banking Outsourcing Market By Application (USD Billion, 2022-2035)

Cell Line Development
Biobanking
Cell Therapy
Regenerative Medicine
Research and Development

UK Cell Banking Outsourcing Market By Cell Type (USD Billion, 2022-2035)

Stem Cells
Somatic Cells
Germ Cells
Immortalized Cell Lines
Primary Cells

UK Cell Banking Outsourcing Market By Service Type (USD Billion, 2022-2035)

Cell Storage
Cell Processing
Cell Distribution
Quality Control
Regulatory Compliance

UK Cell Banking Outsourcing Market By End User (USD Billion, 2022-2035)

Pharmaceutical Companies
Biotechnology Firms
Academic Institutions
Research Organizations
Contract Research Organizations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”